Please Wait
Applying Filters...
menu
    • menu
    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Imatinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 936Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Shorla Expands U.S. Presence With Sales, Market Access Teams
    Shorla Expands U.S. Presence With Sales, Market Access Teams

    04 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250304027981/en

    BUSINESSWIRE
    04 Mar 2025
    Share Share
    Shilpa Medicare’s JV Oncosol gets USFDA approval for IMKELDI
    Shilpa Medicare’s JV Oncosol gets USFDA approval for IMKELDI

    28 Nov 2024

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/shilpa-medicares-jv-oncosol-gets-usfda-approval-for-imkeldi-16490

    INDPHARMAPOST
    28 Nov 2024
    Share Share
    Shorla gains FDA nod for 1st oral version of Novartis' Gleevec
    Shorla gains FDA nod for 1st oral version of Novartis' Gleevec

    27 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241125044117/en/Shorla-Oncology-Announces-FDA-Approval-of-IMKELDI-imatinib-Oral-Solution-an-Oral-Liquid-for-the-Treatment-of-Certain-Forms-of-Leukemia-and-Other-Cancers

    BUSINESSWIRE
    27 Nov 2024
    Share Share
    Kura Oncology Reports Preclinical Data For Ziftomenib In GIST
    Kura Oncology Reports Preclinical Data For Ziftomenib In GIST

    24 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/10/24/2968596/35186/en/Kura-Oncology-Reports-Preclinical-Data-Supporting-Opportunity-for-Ziftomenib-in-Treatment-of-Gastrointestinal-Stromal-Tumors-GIST.html

    GLOBENEWSWIRE
    24 Oct 2024
    Share Share
    Kura Oncology Announces FDA Clearance Of IND For Ziftomenib In GIST
    Kura Oncology Announces FDA Clearance Of IND For Ziftomenib In GIST

    08 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/08/2926821/35186/en/Kura-Oncology-Announces-FDA-Clearance-of-IND-Application-for-Menin-Inhibitor-Ziftomenib-in-Advanced-Gastrointestinal-Stromal-Tumors-GIST.html

    GLOBENEWSWIRE
    08 Aug 2024
    Share Share
    Aerovate's stock plummets after sole product fails in PAH trial
    Aerovate's stock plummets after sole product fails in PAH trial

    18 Jun 2024

    // Zoey Becker FIERCE PHARMA

    https://www.fiercepharma.com/pharma/aerovate-therapeutics-shares-plummet-after-inhaled-version-novartis-gleevac-misses-phase-2b

    Zoey Becker FIERCE PHARMA
    18 Jun 2024
    Share Share